"Alogliptin Tablets Specified Drug-use Survey Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"

CompletedOBSERVATIONAL

Enrollment

964

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Alogliptin

Alogliptin tablets

Trial Locations (2)

Osaka

Tokyo